Kamu erişimi zorunlu olan makaleler - Richard J. Lin, MD, PhDDaha fazla bilgi edinin
Bir yerde sunuluyor: 66
Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation
JU Peled, ALC Gomes, SM Devlin, ER Littmann, Y Taur, AD Sung, ...
New England Journal of Medicine 382 (9), 822-834, 2020
Zorunlu olanlar: US National Institutes of Health
Paraneoplastic thrombocytosis: the secrets of tumor self-promotion
RJ Lin, V Afshar-Kharghan, AI Schafer
Blood, The Journal of the American Society of Hematology 124 (2), 184-187, 2014
Zorunlu olanlar: US National Institutes of Health
Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF
E Feige, S Yokoyama, C Levy, M Khaled, V Igras, RJ Lin, S Lee, ...
Proceedings of the National Academy of Sciences 108 (43), E924-E933, 2011
Zorunlu olanlar: US National Institutes of Health
Impact of TP53 Genomic Alterations in Large B-Cell Lymphoma Treated With CD19-Chimeric Antigen Receptor T-Cell Therapy
R Shouval, A Alarcon Tomas, JA Fein, JR Flynn, E Markovits, S Mayer, ...
Journal of clinical oncology 40 (4), 369-381, 2022
Zorunlu olanlar: US National Institutes of Health
Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
D Sermer, C Batlevi, ML Palomba, G Shah, RJ Lin, MA Perales, M Scordo, ...
Blood advances 4 (19), 4669-4678, 2020
Zorunlu olanlar: US National Institutes of Health
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results
JH Park, K Nath, SM Devlin, CS Sauter, ML Palomba, G Shah, P Dahi, ...
Nature medicine 29 (7), 1710-1717, 2023
Zorunlu olanlar: US National Institutes of Health
Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies
R Stuver, GL Shah, NS Korde, LE Roeker, AR Mato, CL Batlevi, DJ Chung, ...
Cancer cell 40 (6), 590-591, 2022
Zorunlu olanlar: US National Institutes of Health
Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP53 alterations
RJ Lin, C Ho, PD Hilden, JN Barker, SA Giralt, PA Hamlin, AA Jakubowski, ...
British journal of haematology 184 (6), 1006-1010, 2019
Zorunlu olanlar: US National Institutes of Health
Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes
RL Olin, C Fretham, MC Pasquini, M Arora, VR Bhatt, B Derman, SA Giralt, ...
Blood advances 4 (12), 2810-2820, 2020
Zorunlu olanlar: US Department of Defense, US National Institutes of Health
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma
A Alarcon Tomas, JA Fein, S Fried, JR Flynn, SM Devlin, WB Fingrut, ...
Leukemia 37 (1), 154-163, 2023
Zorunlu olanlar: US National Institutes of Health
Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma
RJ Lin, SM Lobaugh, M Pennisi, HT Chan, Y Batlevi, JD Ruiz, TA Elko, ...
Haematologica 106 (1), 255, 2020
Zorunlu olanlar: US National Institutes of Health
Anemia in general medical inpatients prolongs length of stay and increases 30-day unplanned readmission rate
RJ Lin, AT Evans, AE Chused, ME Unterbrink
Southern medical journal 106 (5), 316, 2013
Zorunlu olanlar: US National Institutes of Health
Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies
RJ Lin, TA Elko, SM Devlin, A Shahrokni, AA Jakubowski, PB Dahi, ...
Bone marrow transplantation 55 (1), 157-164, 2020
Zorunlu olanlar: US National Institutes of Health
Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma
RJ Lin, M Behera, CS Diefenbach, CR Flowers
Blood, The Journal of the American Society of Hematology 130 (20), 2180-2185, 2017
Zorunlu olanlar: US National Institutes of Health
The barriers to high-quality inpatient pain management: a qualitative study
RJ Lin, MC Reid, LL Liu, AE Chused, AT Evans
American Journal of Hospice and Palliative Medicine® 32 (6), 594-599, 2015
Zorunlu olanlar: US National Institutes of Health
Dyspnea in palliative care: expanding the role of corticosteroids
RJ Lin, RD Adelman, SS Mehta
Journal of Palliative Medicine 15 (7), 834-837, 2012
Zorunlu olanlar: US National Institutes of Health
Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
H Hubbeling, EA Silverman, L Michaud, AA Tomas, R Shouval, J Flynn, ...
Transplantation and cellular therapy 29 (4), 259. e1-259. e10, 2023
Zorunlu olanlar: US National Institutes of Health
Relapse after allogeneic stem cell transplantation of acute myelogenous leukemia and myelodysplastic syndrome and the importance of second cellular therapy
CZ Brambilla, SM Lobaugh, JD Ruiz, PB Dahi, AD Goldberg, JW Young, ...
Transplantation and cellular therapy 27 (9), 771. e1-771. e10, 2021
Zorunlu olanlar: US National Institutes of Health, Robert Wood Johnson Foundation, AIRC …
Therapeutic anticoagulation in patients with primary brain tumors or secondary brain metastasis
RJ Lin, DL Green, GL Shah
The oncologist 23 (4), 468-473, 2018
Zorunlu olanlar: US National Institutes of Health
Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults
RJ Lin, PD Hilden, TA Elko, PB Dahi, A Shahrokni, AA Jakubowski, ...
Blood Advances 3 (1), 12-20, 2019
Zorunlu olanlar: US National Institutes of Health
Yayıncılık ve maddi kaynak bilgileri otomatik olarak bir bilgisayar programı tarafından belirlenmektedir